why choose us

First received: February 17, 2023

Clinical Trial: Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections

Study Status: Completed

Recruit Status: RECRUITING

Condition: Retinal Disease

Study Type: INTERVENTIONAL


Official Title: Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Pain and Corneal Epitheliopathy

Brief Summary: This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections.

Read more